Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of the Thyroid Cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing.

Thyroid : official journal of the American Thyroid Association - 1 Feb 2024

Tarasova Valentina D, Tsai Jill, Masannat Jude, Hernandez Prera Juan C, Hallanger Johnson Julie, Veloski Colleen, Agosto Salgado Sarimar, McIver Bryan, Drusbosky Leylah M, Chung Christine H

Abstract excerpt

Background: The limited availability of targeted therapies in thyroid cancer (TC) has challenged conventional treatment algorithms and has established urgency for the identification of targetable genomic abnormalities. In addition to widely adopted tissue-based next-generation sequencing (NGS), plasma-based circulating tumor DNA (ctDNA) NGS is rapidly emerging as a genomic biomarker detection method and is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Proline

Share to Thyroid Cancer Diagnosis and Treatment

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 37962267
DOI: 10.1089/thy.2023.0204

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of the Thyroid Cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing.PMID 37962267Read ↗

Evaluating the prognostic potential of circulating cell-free DNA in advanced thyroid cancer.Semantic proximity Read ↗

Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma.Semantic proximity Read ↗

Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid Carcinoma.Semantic proximity Read ↗

Tumor-informed liquid biopsy for monitoring thyroid cancer: a proof-of-concept study.Semantic proximity Read ↗

Genomic landscape characterization and comparative analysis of tissue and liquid-based next-generation sequencing in anaplastic thyroid carcinoma in TaiwanSemantic proximity Read ↗

Analytical Performance Evaluation of a 523-Gene Circulating Tumor DNA Assay for Next-Generation Sequencing-Based Comprehensive Tumor Profiling in Liquid Biopsy Samples.Semantic proximity Read ↗

Molecular predictive biomarker testing in advanced thyroid cancer - a European consensus.Semantic proximity Read ↗

Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers.Semantic proximity Read ↗

Genetic landscape of 482 thyroid carcinomas: analysis with the national datacenter for cancer genomic medicine in Japan.Semantic proximity Read ↗

Targeted next‑generation sequencing of cancer‑related genes in thyroid carcinoma: A single institution's experienceSemantic proximity Read ↗

Next-generation sequencing in thyroid cancer.Semantic proximity Read ↗

Genomics and Multi-Omics to Guide Clinical Management in Thyroid CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.